Extracorporeal whole body hyperthermia treatments for HIV infection and AIDS

ASAIO Journal

Volumn 43, Issue 5, 1997, Pages

  Ash, Stephen R ^a,b   Steinhart, C R ^c   Curfman, M F ^b   Gingrich, C H ^a   Sapir, D A ^b   Ash, E L ^d   Fausset, J M ^e   Yatvin, M B ^f  

^a HemoCleanse Incorporated   (United States)

^b St Elizabeth Hospital   (United States)

^c Mercy Special Immunology Services   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e IDT Inc   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DRUG PRODUCTS; DRUG THERAPY; ENZYME INHIBITION; ENZYMES;

AIDS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; WHOLE BODY HYPERTHERMIA TREATMENTS;

PATIENT TREATMENT;

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CORE TEMPERATURE; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERTHERMIA; LYMPHOCYTE COUNT; MALE; TREATMENT PLANNING; VIRUS INFECTION;

EID: 0031238964     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199709000-00101     Document Type: Conference Paper

References (45)

1. Yarchoan R, Lietzau JA, Nguyen B-Y, et al: Randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection. J Infect Dis 169: 9-17, 1994.
2. Murphy R: Clinical aspects of human immunodeficiency virus disease; clinical rationale for treatment. J Infect Dis 71 (Suppl 2): S81-87, 1995.
3. Advisory Group on HIV Early Intervention, 2nd ed, American Medical Association. Human immunodeficiency virus early intervention physician guidelines. Arch Fam Med 3: 988-1002, 1994.
4. Goldschmidt RH, Dong BJ, Legg JJ: Current report-HIV antiretroviral strategies revisited. J Am Board Fam Pract 8: 62-69, 1995.
5. Abrams DI, Goldman AI, Launer C, et al: A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. N Engl J Med 330: 657-662, 1994.
6. Hammer SM, Kessler HA, Saag MS: Issues in combination antiretroviral therapy: a review. J AIDS and Hum Retrovir 7(Suppl 2): S24-S37, 1994.
7. + T-lymphocyte measures in the treatment of individuals infected with human immunode-ficiency virus type 1. Arch Intern Med 154: 1561-1573, 1994.
8. Volberding PA, Graham NMH: Initiation of antiretroviral therapy in HIV infection: a review of interstudy consistencies. J AIDS and Hum Retrovir 7(Suppl 2): S12-S23, 1997.
9. Fischl MA, Stanley K, Collier AC, et al: Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. Ann Intern Med 122: 24-32, 1995.
10. Murray HW, Squires KE, Weiss W, et al. Stavudine in patients with AIDS and AIDS-related complex: AIDS Clinical Trials Group 089. J Infect Dis 171 (Suppl 2):, 1995.
11. Saag MS: What to do when zidovudine fails. N Engl J Med 330: 706-707, 1994.
12. Volberding P: The need for additional options in the treatment of human immunodeficiency virus infection. J Infect Dis 171 (Suppl 2): S150-S154, 1995.
13. Larder B, Kemp S, Harrigan R: Potential Mechanism for sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy, Science 269: 696-699, 1995.
14. Parks LC, Minaberry D, Smith DP, et al: Treatment of far-advanced bronchogenic carcinoma by extracorporally induced systemic hyperthermia. J Thorac Cardiovasc Surg 78: 883-897, 1979.
15. Gabrielle P, Orecchia R, Rana R, et al: Hyperthermia alone in the treatment of recurrences of malignant tumors. Cancer 66: 2191-2195, 1990.
16. Olzewski WL, Grzelak I, Ziolkowska A, Engeset A: Effect of local hyperthermia on lymph immune cells and lymphokines of normal skin. J Surg Oncol 41: 109, 1989.
17. Robins HI, Hugander A, Cohen JD: Whole-body hyperthermia in the treatment of neoplastic disease. Radiol Clin North Am 27: 803-830, 1989.
18. Storm FK: Clinical hyperthermia and chemotherapy. Radiol Clin North Am 27: 621-635, 1989.
19. Pettigrew RT, Galt JM, Ludgate CM, Smith AN: Clinical effects of whole-body hyperthermia in advanced malignancy. Br Med J 48: 679-682, 1974.
20. Yatvin MB: An approach to AIDS therapy using hyperthermia and membrane modification. (Abstract). Fourth Annual Meeting Amer Soc Clin Hyperthermic Oncol, Houston, Texas, November 5-7, 1987.
21. Yatvin MB: An approach to AIDS therapy using hyperthermia and membrane modification. Medical Hypotheses 27: 163-165, 1988.
22. Weatherburn H: Hyperthermia and AIDS treatment. Brit J Radiol 61: 862-868, 1988.
23. Marcial-Vega V, Arens L, Lasslo L: In vitro heat sensitivity on the AIDS virus. (Abstract). Proc Am Soc Clin Hypertherm Oncol 1990.
24. McDougal JS, Martin LS, Cort SP, et al; Thermal inactivation of the acquired immunodeficiency syndrome virus human T. lymphotropic virus III/lymphadenopathy associated virus with special reference to antihemophilic factor. J Clin Invest 76: 875-880, 1985.
25. Spire B, Barre-Sinoussi F, Dormant D, et al: Inactivation of lymphadenopathy associated virus by heat, gamma rays, and ultraviolet light. Lancet 1: 188-189, 1985.
26. Wong GHW, McHugh T, Weber R, Goeddel DV: Tumor necrosis factor selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation. Proc Natl Acad Sci USA 88: 4372-4375, 1991.
27. Malkovsky M, Bartz SR, Mackenzie D, Radkte BE, et al: Are γδ cells important for elimination of virus infected cells? J Med Primatology 21: 113, 1992.
28. Yatvin MB, Stowell MHB, Steinhart CR: Shedding light on the use of heat to treat HIV infection. Oncology 50: 380-389, 1993.
29. Yatvin MB, Stowell MHB, Steinhart CR: Is there a role for hyperthermia in the treatment of HIV infection? AIDS Patient Care February 1993;5-9.
30. Pantaleo G, Graziozi C, Demarest JF, et al: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362: 355, 1993.
31. Pantaleo G, Graziozi C, Fauci AS: The role of lymphoid organs in the immunopathogenesis of HIV infection. AIDS 7: S19, 1993.
32. Cohen OJ, Pantaleo G, Holodniy M, et al: Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc Nat Acad Sci 92: 6017-21, 1995.
33. Pantaleo G, Menzo S, Vaccarezza M, et al; Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332: 209-16, 1995.
34. Olzewski WL, Grzelak I, Ziolkowska A, Engeset A: Effect of local hyperthermia on lymph immune cells and lymphokines of normal skin. J Surg Oncol 41: 109, 1989.
35. Moore TC, Nur K, Storm FK: Localized deep hyperthermia increases the traffic of lymphocytes through peripheral lymph nodes in sheep in vivo. J Surg Oncol 35: 75-83, 1987.
36. Pachel C, Todd JA, Kern DG, et al: Rapid and precise quantification of HIV RNA in plasma using a branched DNA signal amplification assay. J AIDS and Hum Retrovir 8: 446-454, 1995.
37. Bull JM, Lees DE, Schuette WH, Whang-Peng J, et al: Whole body hyperthermia: a phase-I trial of a potential adjutant to chemotherapy. Ann Intern Med 90: 317-323, 1979.
38. Bull JM, Lees DE, Schuette WH, Smith R, Glatstein E, DeVita VT: Immunological and physiological responses to whole-body hyperthermia. Presented at the Third International Symposium: Cancer Therapy by Hyperthermia, Drugs and Radiation held at Colorado State University, Ft. Collins, Colorado, June 22-26, 1980.
39. Bull JMD: An update on the anticancer effects of a combination of chemotherapy and hyperthermia. Cancer Res 44: 487, 1984.
40. Eisler D, Landauer B, Hipp R, et al: Experiences with therapeutic whole body hyperthermia. Anesthetist 34: 299-305, 1985.
41. Steinhart CR, Ash SR, Gingrich C, Sapir D, Keeling GN, Yatvin MB: The effect of whole body hyperthermia on AIDS patients with Kaposi's sarcoma: a pilot study. J AIDS and Hum Retrovir 11: 271-281, 1996.
42. Ash SR: Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 18: 355-362, 1994.
43. Bicher H: Local hyperthermia of Kaposi's sarcoma in AIDS patients (Abstract). Proc Am Soc Clin Hypertherm Oncol 1990.
44. Ash SR, Blake DE, Carr DJ, Baker K, Echard TG: The Biologic-DT: hemodialysis simplified. In: Artif Organs Proceedings of the International Symposium on Artificial Organs Salt Lake City, Utah, January 1986, pp.263-77.
45. Ash SR, Blake DE, Carr DJ, Carter C, Howard T, Makowa L: Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the Biologic-DT). Int J Artif Organs 15: 151-61, 1992.